BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hojsak I. Probiotics in Functional Gastrointestinal Disorders. Adv Exp Med Biol 2019;1125:121-37. [PMID: 30578460 DOI: 10.1007/5584_2018_321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Youssef M, Ahmed HY, Zongo A, Korin A, Zhan F, Hady E, Umair M, Shahid Riaz Rajoka M, Xiong Y, Li B. Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases. Int J Mol Sci 2021;22:11290. [PMID: 34681948 DOI: 10.3390/ijms222011290] [Reference Citation Analysis]
2 Jadrešin O, Sila S, Trivić I, Mišak Z, Kolaček S, Hojsak I. Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study. Clin Nutr 2020;39:3645-51. [PMID: 32362486 DOI: 10.1016/j.clnu.2020.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Saviano A, Brigida M, Migneco A, Gunawardena G, Zanza C, Candelli M, Franceschi F, Ojetti V. Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin? Medicina (Kaunas) 2021;57:643. [PMID: 34201542 DOI: 10.3390/medicina57070643] [Reference Citation Analysis]
4 Perceval C, Szajewska H, Indrio F, Weizman Z, Vandenplas Y. Prophylactic use of probiotics for gastrointestinal disorders in children. Lancet Child Adolesc Health 2019;3:655-62. [PMID: 31279590 DOI: 10.1016/S2352-4642(19)30182-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
5 Kipkoech C, Kinyuru JN, Imathiu S, Meyer-Rochow VB, Roos N. In Vitro Study of Cricket Chitosan's Potential as a Prebiotic and a Promoter of Probiotic Microorganisms to Control Pathogenic Bacteria in the Human Gut. Foods 2021;10:2310. [PMID: 34681361 DOI: 10.3390/foods10102310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Reference Citation Analysis]
7 Baù M, Moretti A, Bertoni E, Vazzoler V, Luini C, Agosti M, Salvatore S. Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study. Pediatr Gastroenterol Hepatol Nutr 2020;23:35-48. [PMID: 31988874 DOI: 10.5223/pghn.2020.23.1.35] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]